New indole-isoxazolone derivatives: Synthesis, characterisation and in vitro SIRT1 inhibition studies

dc.contributor.authorPanathur, N.
dc.contributor.authorGokhale, N.
dc.contributor.authorUdayakumar, U.
dc.contributor.authorKoushik, P.V.
dc.contributor.authorYogeeswari, P.
dc.contributor.authorSriram, D.
dc.date.accessioned2026-02-05T09:33:43Z
dc.date.issued2015
dc.description.abstractA new series of indole-isoxazolone hybrids bearing substituted amide, substituted [(1,2,3-triazol-4-yl)methoxy]methyl group or substituted benzylic ether at position-2 of the indole nucleus was synthesised using a facile synthetic route and the molecules were characterised using spectroscopic techniques. The molecules were screened against three human cancer cell lines to evaluate their in vitro cytotoxic property. Most of the trifluoromethyl substituted derivatives exhibited better growth inhibition activity than their methyl substituted analogues. The SIRT1 inhibition activity of two potent molecules (I17 and I18) was investigated and the SIRT1 IC<inf>50</inf> values are 35.25 and 37.36 ?M, respectively for I17 and I18. The molecular docking studies with SIRT1 enzyme revealed favourable interactions of the molecule I17 with the amino acids constituting the receptor enzyme. © 2015 Elsevier Ltd. All rights reserved.
dc.identifier.citationBioorganic and Medicinal Chemistry Letters, 2015, 25, 14, pp. 2768-2772
dc.identifier.issn0960894X
dc.identifier.urihttps://doi.org/10.1016/j.bmcl.2015.05.015
dc.identifier.urihttps://idr.nitk.ac.in/handle/123456789/26279
dc.publisherElsevier Ltd
dc.subject3 methyl 4 [(1 methyl 1h indol 3 yl)methylene]isoxazolone 5 one derivative
dc.subject4 [[2 (benzyloxymethyl) 5 fluoro 1 methyl 1h indol 3 yl]methylene] 3 methyl isoxazol 5 (4h) one
dc.subject4 [[2 [[(1 benzyl 1h 1,2,3 triazol 4 yl)methoxy]methyl] 5 fluoro 1 methyl 1h indol 3 yl]methtylene] 3 methylisoxazol 5 one
dc.subjectamide
dc.subjectantineoplastic agent
dc.subjectaspartic acid
dc.subjectglutamine
dc.subjectindole derivative
dc.subjectisoleucine
dc.subjectisoxazole derivative
dc.subjectsirtuin 1
dc.subjectunclassified drug
dc.subjecthistone deacetylase inhibitor
dc.subjectindole
dc.subjectprotein binding
dc.subjectantineoplastic activity
dc.subjectArticle
dc.subjectbreast metastasis
dc.subjectcancer cell line
dc.subjectcancer inhibition
dc.subjectchemical analysis
dc.subjectchemical reaction
dc.subjectclinical evaluation
dc.subjectcontrolled study
dc.subjectcytotoxicity
dc.subjectdrug structure
dc.subjectdrug synthesis
dc.subjectenzyme inhibition
dc.subjectgrowth inhibition
dc.subjectHT 29 cell line
dc.subjecthuman
dc.subjecthuman cell
dc.subjectIC50
dc.subjectin vitro study
dc.subjectMCF 7 cell line
dc.subjectmetabolic stability
dc.subjectmolecular docking
dc.subjectpharmacophore
dc.subjectprotein interaction
dc.subjectreaction analysis
dc.subjectantagonists and inhibitors
dc.subjectbinding site
dc.subjectcell proliferation
dc.subjectchemistry
dc.subjectdrug effects
dc.subjectenzyme active site
dc.subjectHEK293 cell line
dc.subjectmetabolism
dc.subjectstructure activity relation
dc.subjectsynthesis
dc.subjecttumor cell line
dc.subjectBinding Sites
dc.subjectCatalytic Domain
dc.subjectCell Line, Tumor
dc.subjectCell Proliferation
dc.subjectHEK293 Cells
dc.subjectHistone Deacetylase Inhibitors
dc.subjectHumans
dc.subjectIndoles
dc.subjectIsoxazoles
dc.subjectMolecular Docking Simulation
dc.subjectProtein Binding
dc.subjectSirtuin 1
dc.subjectStructure-Activity Relationship
dc.titleNew indole-isoxazolone derivatives: Synthesis, characterisation and in vitro SIRT1 inhibition studies

Files

Collections